Traveling with Multiple Sclerosis Isn’t Always Easy By Penelope Conway Before multiple sclerosis came along I was an avid traveler. At different times I even lived and worked In Germany, France, Mexico and Jamaica....
Additional Published Results from National MS Society-Funded CCSVI Study/About-the-Society/News/Additional-Published-Results-from-National-MS-Soci … read morePosted At: National MS Society
Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose studyMultiple Sclerosis Journal, Ahead...
Patient selection for trialsMultiple Sclerosis Journal, Volume 23, Issue 12, Page 1636-1641, October 2017. … read morePosted At: MS Journal
Researchers Suggest That Vitamin D May Protect the Brain in People at Risk for Developing MS/About-the-Society/News/Researchers-Suggest-That-Vitamin-D-May-Protect-the … read morePosted At: National MS Society
Liver injury associated with dimethyl fumarate in multiple sclerosis patientsMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Join Our Mailing List
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosisPosted At: Science Daily
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting proteinPosted At: Science Daily
- Animal models of multiple sclerosis: From rodents to zebrafish
- Inclusion criteria used in trials of people with progressive multiple sclerosis
- Do cannabinoids ease multiple sclerosis symptoms?Posted At: Medical News Today
- Results Reported from Innovative “MS-SMART” Clinical Trial in Secondary Progressive MS Presented at
- Hidden cost of pembrolizumab therapy